
Sign up to save your podcasts
Or
In this episode, Anthony and Bernie are joined once again by special guest and hematology expert, Dr. Dale Bixby, to discuss the recent publication of the QUANTUM-First study of quizartinib in newly diagnosed AML. Should this study change practice in FLT3-ITD+ AML? Have we made a "Quantum Leap" in the treatment of these patients? Listen for a fun-filled discussion of the data!
Notable References:
4.5
2828 ratings
In this episode, Anthony and Bernie are joined once again by special guest and hematology expert, Dr. Dale Bixby, to discuss the recent publication of the QUANTUM-First study of quizartinib in newly diagnosed AML. Should this study change practice in FLT3-ITD+ AML? Have we made a "Quantum Leap" in the treatment of these patients? Listen for a fun-filled discussion of the data!
Notable References:
26 Listeners
493 Listeners
185 Listeners
3 Listeners
7,928 Listeners
755 Listeners
12 Listeners
51 Listeners
52 Listeners
133 Listeners
1 Listeners
169 Listeners
48 Listeners
39 Listeners
3 Listeners